M J Burke

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi request reprint Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice
    M J Burke
    Department of Psychiatry and Behavioural Sciences, University of Kansas School of Medicine, Wichita 67214, USA
    Clin Pharmacokinet 37:147-65. 1999
  2. ncbi request reprint Trends in undergraduate medical education: clinical clerkship learning objectives
    Michael J Burke
    University of Kansas School of Medicine, Department of Psychiatry and Behavioral Sciences, 1010 N Kansas, Wichita, KS 67214, USA
    Acad Psychiatry 30:158-65. 2006
  3. ncbi request reprint Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression
    Michael J Burke
    Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Wichita, KS
    J ECT 22:218-22. 2006
  4. ncbi request reprint Implementing a systematic course/clerkship peer review process
    Michael J Burke
    Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Witchita, 67214, USA
    Acad Med 77:930-1. 2002
  5. ncbi request reprint Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma
    Michael J Burke
    Division of Hematology Oncology Transplant, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Pediatr Blood Cancer 50:679-80. 2008
  6. ncbi request reprint Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors
    Michael J Burke
    Division of Hematology, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60614 3394, USA
    Pediatr Blood Cancer 49:196-8. 2007

Detail Information

Publications6

  1. ncbi request reprint Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice
    M J Burke
    Department of Psychiatry and Behavioural Sciences, University of Kansas School of Medicine, Wichita 67214, USA
    Clin Pharmacokinet 37:147-65. 1999
    ..Recommendations are made for the practical application of TDM and the directions for further research...
  2. ncbi request reprint Trends in undergraduate medical education: clinical clerkship learning objectives
    Michael J Burke
    University of Kansas School of Medicine, Department of Psychiatry and Behavioral Sciences, 1010 N Kansas, Wichita, KS 67214, USA
    Acad Psychiatry 30:158-65. 2006
    ....
  3. ncbi request reprint Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression
    Michael J Burke
    Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Wichita, KS
    J ECT 22:218-22. 2006
    ..This study explored the use of electroconvulsive therapy (ECT) in the pivotal study of vagus nerve stimulation (VNS) for treatment-resistant depression...
  4. ncbi request reprint Implementing a systematic course/clerkship peer review process
    Michael J Burke
    Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Witchita, 67214, USA
    Acad Med 77:930-1. 2002
    ....
  5. ncbi request reprint Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma
    Michael J Burke
    Division of Hematology Oncology Transplant, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Pediatr Blood Cancer 50:679-80. 2008
    ..Therapies that have shown to improve symptoms in these patients have ranged from ACTH and corticosteroids, to intravenous gammaglobulin and plasmapheresis. We report our experience with Rituximab in a patient with neuroblastoma and OMS...
  6. ncbi request reprint Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors
    Michael J Burke
    Division of Hematology, Children s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60614 3394, USA
    Pediatr Blood Cancer 49:196-8. 2007
    ..Our experience has shown that treatment of EFT patients with tandem HDC with APHPCR may benefit a subgroup of high-risk patients in whom optimal local therapy is not possible...